| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +3 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hyperaldosteronism, familial, type IV +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Idiopathic generalized epilepsy +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 | |
| | | Single nucleotide variant (intron variant) | Epilepsy, childhood absence, susceptibility to, 6 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Idiopathic generalized epilepsy +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +1 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 | |
| | | Single nucleotide variant (missense variant) | Idiopathic generalized epilepsy +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +2 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, childhood absence, susceptibility to, 6 +2 more | GConflicting classifications of pathogenicity |